Review Article

Bacille-Calmette-Guerin non-responders: how to manage
Friedrich-Carl von Rundstedt, Seth P. Lerner
Standard cystectomy fits all: truth or myth?
Beat Roth, George N. Thalmann
Upper urinary tract disease: what we know today and unmet needs
Romain Mathieu, Karim Bensalah, Ilaria Lucca, Aurélie Mbeutcha, Morgan Rouprêt, Shahrokh F. Shariat
Risk based neoadjuvant chemotherapy in muscle invasive bladder cancer
Isuru S. Jayaratna, Neema Navai, Colin P. N. Dinney
Indications for biopsy and the current status of focal therapy for renal tumours
Ricardo R.N. Leão, Patrick O. Richard, Michael A.S. Jewett
Outlining the limits of partial nephrectomy
Sameer Chopra, Raj Satkunasivam, Chandan Kundavaram, Gangning Liang, Inderbir S. Gill
Cytoreductive surgery in the era of targeted molecular therapy
Arun Z. Thomas, Mehrad Adibi, Leonardo D. Borregales, Jose A. Karam, Christopher G. Wood
Sequence of treatment in locally advanced and metastatic renal cell carcinoma
Stefanie Fischer, Silke Gillessen, Christian Rothermundt
The current and future role of magnetic resonance imaging in prostate cancer detection and management
Jan Philipp Radtke, Dogu Teber, Markus Hohenfellner, Boris A. Hadaschik
Active surveillance and focal therapy for low-intermediate risk prostate cancer
Laurence Klotz
Hormonal therapy and chemotherapy in hormone-naive and castration resistant prostate cancer
Federica Recine, Cora N. Sternberg
Mechanisms of resistance in castration-resistant prostate cancer (CRPC)
Thenappan Chandrasekar, Joy C. Yang, Allen C. Gao, Christopher P. Evans
Advances in the treatment of testicular cancer
Yaron Ehrlich, David Margel, Marc Alan Lubin, Jack Baniel

Review Article

Strategies for maintaining penile size following penile implant
King Chien Joe Lee, Gerald B. Brock
Phalloplasty for the genetic male
Giulio Garaffa, Gabriele Antonini, Vincenzo Gentile, David J. Ralph
Exogenous testosterone: a preventable cause of male infertility
Lindsey E. Crosnoe, Ethan Grober, Dana Ohl, Edward D. Kim
Premature ejaculation: do we have effective therapy?
Ege Can Serefoglu, Theodore R. Saitz, Landon Trost, Wayne J.G. Hellstrom
Peyronie’s disease: current therapy
Clay M. Pendleton, Run Wang

Expert Opinions on Challenging Cases

Commentary on the myths of Peyronie’s disease
Alex K Wu, Tom F Lue

Commentary

Randall plaque versus renal stone?
Thomas Chi, Joe Miller, Marshall L. Stoller

Original Article

Surgical treatment of Peyronie’s disease by modified 16-dot placation in China
Wen Ji Li, Haijun Yao, Ke Zhang, Zhikang Cai, Jun Da, Mingxi Xu, Zhong Wang
Does normalizing PSA after successful treatment of chronic prostatitis with high PSA value exclude prostatic biopsy?
Sherif Azab, Ayman Osama, Mona Rafaat

Review Article

Future perspectives of prostate cancer therapy
Murali Gururajan, Edwin M. Posadas, Leland W. K. Chung
Small RNA and its application in andrology and urology
Ji Wang, Long-Cheng Li
TGF-β mediated DNA methylation in prostate cancer
Chung Lee, Qiang Zhang, Xaolin Zi, Atreya Dash, Marcelo B Soares, Farahnaz Rahmatpanah, Zhenyu Jia, Michael McClelland, Dan Mercola
Regenerative technology for future therapy of erectile dysfunction
Ji-Kan Ryu, Jun-Kyu Suh
Phytotherapy: emerging therapeutic option in urologic disease
Sae Woong Kim
Contemporary and future insights into fertility preservation in male cancer patients
Ashok Agarwal, Chloe Ong, Damayanthi Durairajanayagam
Application of Raman spectroscopy in Andrology: non-invasive analysis of tissue and single cell
Yufei Liu, Yong Zhu, Zheng Li
Urinary adverse effects of pelvic radiotherapy
Daniel Liberman, Brian Mehus, Sean P. Elliott
Cystine nephrolithiasis
Hasan Fattah, Yasmin Hambaroush, David S. Goldfarb
Outlining the limits of partial nephrectomy
Sameer Chopra, Raj Satkunasivam, Chandan Kundavaram, Gangning Liang, Inderbir S. Gill

Editorial

PIVOT and the challenges of localized prostate cancer care
Aviva E. Weinberg, James D. Brooks

Research Highlight

Could tivozanib be a new potent pan-VEGF inhibitor in RCC therapy?
Zsuzsanna Mihály, Alexisz Panajotu, Balázs Győrffy

Research Highlights

Enzalutamide: the emperor of all anti-androgens
Emmanuel S. Antonarakis

Review Articles

Androgen receptor gene mutation, rearrangement, polymorphism
Kurtis Eisermann, Dan Wang, Yifeng Jing, Laura E. Pascal, Zhou Wang
Androgen receptor epigenetics
Changmeng Cai, Xin Yuan, Steven P. Balk
Androgen receptor genomic regulation
Hong-Jian Jin, Jung Kim, Jindan Yu
Decoding the androgen receptor splice variants
Changxue Lu, Jun Luo
Epithelial mesenchymal transition (EMT) in prostate growth and tumor progression
Campbell M. Grant, Natasha Kyprianou
Steroid hormone synthetic pathways in prostate cancer
Elahe A. Mostaghel
The role of microRNAs in prostate cancer progression
U-Ging Lo, Diane Yang, Jer-Tsong Hsieh
Near-infrared fluorescence and nuclear imaging and targeting of prostate cancer
Jason Wu, Dongfeng Pan, Leland W.K. Chung
Novel non-AR therapeutic targets in castrate resistant prostate cancer
Paul J. Toren, Martin E. Gleave

Review Article

Kidney stone risk following Roux-en-Y gastric bypass surgery
Benjamin K. Canales, Ricardo D. Gonzalez

Review Article

Advances in ureteral stents
Hilary Brotherhood, Dirk Lange, Ben H. Chew

Below are the latest Translational Andrology and Urology articles published online ahead of print publication.


Editorial


Original Article